The Bioeconomy’s Key Enabling Technologies Conference & Exhibition
EuropaBio is thrilled to announce that the European Forum for Industrial Biotechnology (EFIB), and ACDV are joining forces with BIOKET 2025 in Brussels from March 11-13. This collaboration brings a significant policy-making component to our event, providing an unparalleled opportunity to shape the bioeconomy sector’s future.
Join us on March 11th for an impactful Open Plenary Session dedicated to Policy Makers:
Biotechnology & Biomanufacturing for Europe: Building a critical EU future
Biotechnology and Biomanufacturing are changing industrial ecosystems within a global race to establish resilient supply chains and competitive positions. BIOKET arrives at the heart of Europe with the technologies that drive progress and the companies that deliver outcomes. Our opening plenary will address EU ambition, industrial strategy and the framework needed for Europe to play its full role on the world stage and shape a competitive and resilient future for the European and global bioeconomy.
Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.
Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.
Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.
The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.
Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.
Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.